Pay in 4 interest-free payments of $6.10 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
For researchers who want a single healing peptide to start with, PDA is often the recommended first choice
Larger-volume quotes are available by request
Researched applications In the published preclinical and clinical literature the effects of AOD-9604 are documented in the following areas: Obesity , Phase 2b failure (2007), but a complementary mechanism in combination protocols Lipolysis in animal models , robustly demonstrated (Heffernan 2001, Ng 2009) Inhibition of lipogenesis , demonstrated in hepatocytes and adipocytes Osteoarthritis and cartilage regeneration , emerging Phase 1/2 data (mLuna Pharmaceuticals 2018+) Tendinopathy , preclinical models Age-related sarcopenia (cachexia) , exploratory plans Lipodystrophy , preclinical data in animal models Hyperlipidemia , secondary endpoints in Phase 2 trials Science & studies 4.1 Key publications Heffernan M., Summers R.J., Thorburn A., et al
Thymosin beta-4 peptides have been examined for their effects on inflammatory signaling networks and cellular survival pathways, with studies describing modulation of endothelial behavior, oxidative stress responses, and reparative cell activity in experimental models [7][8]
Mechanism 2
Supports healthy fat metabolism Enhances energy and stamina Boosts mood and mental clarity Promotes liver detoxification Complements medical weight loss programs May reduce fatigue associated with dieting or B12 deficiency What can I expect during the procedure
US$ 25.17
US$ 25.77
US$ 21.76
US$ 27.46
US$ 21.55
US$ 21.25
